According to the National Cancer Institute's Annual Report 2018 to the nation on the status of cancer in recent years, cases of prostate cancer (PCa) have increased slightly in recent years, after decades of steady decline. In response, the United States Preventive Task Force changed its long-term recommendation against PSA screening in May 2018. The new advice: Men 55-69 should discuss the pros and cons with their doctor and decide for themselves whether screening makes sense.
Why not? While the USPSTF acknowledges that PSA testing may offer a potential benefit to a small number of men at this age, it quickly adds that many men "may suffer potential screening damage, including false-positives, the additional ones Testing may require and possible prostate biopsy; about diagnosis and over-treatment; and treatment complications such as incontinence and erectile dysfunction. "
For legions of" well-cared "fellows ̵
"We have been taught to believe that it is virtuous to act in the face of risks to our health," says biomedical ethicist Arthur Caplan, Ph.D., from NYU's Langone Medical Center. "It turns out, however, that this is not always the case, especially if the action you perform, such as PSA screening, does not work very well. Sometimes it is more virtuous to do nothing. "